1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Edaravone
Trade Name:
Radicava
Manufacturer/Distributor:
Mitsubishi Tanabe Pharma America Inc.
Classification:
Treatment for amyotrophic lateral sclerosis
ATC Class:
N07XX14 - edaravone
Status:
active
Notice of Compliance (yyyy/mm/dd):
2019/10/02
Date Marketed in Canada (yyyy/mm/dd):
2019/10/29
Presentation:
Injection: 0.3 mg/mL. DIN: 02475472
Comments:
To slow the loss of function in patients with amyotrophic lateral sclerosis (ALS).
Back to:
Drug Product Listings 
